Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 07, 2024

SELL
$191.17 - $325.63 $1.73 Million - $2.94 Million
-9,043 Reduced 3.92%
221,642 $72.2 Million
Q4 2023

Feb 07, 2024

BUY
$160.99 - $215.69 $6.9 Million - $9.24 Million
42,830 Added 22.8%
230,685 $44 Million
Q3 2023

Nov 17, 2023

BUY
$194.33 - $283.97 $22.4 Million - $32.7 Million
115,155 Added 158.4%
187,855 $37.4 Million
Q2 2023

Aug 09, 2023

SELL
$223.05 - $302.68 $6.7 Million - $9.1 Million
-30,060 Reduced 29.25%
72,700 $20.7 Million
Q1 2023

May 10, 2023

SELL
$175.41 - $217.92 $2.52 Million - $3.13 Million
-14,360 Reduced 12.26%
102,760 $22.3 Million
Q4 2022

Feb 10, 2023

BUY
$204.38 - $296.82 $535,475 - $777,668
2,620 Added 2.29%
117,120 $24.1 Million
Q3 2022

Nov 09, 2022

SELL
$195.21 - $310.53 $8.13 Million - $12.9 Million
-41,630 Reduced 26.66%
114,500 $31.8 Million
Q2 2022

Aug 05, 2022

BUY
$115.91 - $214.48 $1.18 Million - $2.18 Million
10,155 Added 6.96%
156,130 $29.8 Million
Q1 2022

May 06, 2022

SELL
$127.96 - $207.36 $537,432 - $870,912
-4,200 Reduced 2.8%
145,975 $30.3 Million
Q4 2021

Feb 04, 2022

BUY
$165.13 - $241.83 $974,267 - $1.43 Million
5,900 Added 4.09%
150,175 $26.8 Million
Q3 2021

Nov 08, 2021

SELL
$163.99 - $235.57 $3.73 Million - $5.36 Million
-22,755 Reduced 13.62%
144,275 $29.7 Million
Q2 2021

Aug 09, 2021

SELL
$131.45 - $201.49 $10.9 Million - $16.7 Million
-82,815 Reduced 33.15%
167,030 $31.7 Million
Q1 2021

May 12, 2021

SELL
$92.73 - $142.05 $5.49 Million - $8.41 Million
-59,185 Reduced 19.15%
249,845 $32.5 Million
Q4 2020

Feb 12, 2021

BUY
$67.44 - $103.72 $908,416 - $1.4 Million
13,470 Added 4.56%
309,030 $32.1 Million
Q3 2020

Nov 06, 2020

BUY
$42.79 - $75.8 $12.6 Million - $22.4 Million
295,560 New
295,560 $22.4 Million

Others Institutions Holding SWAV

About Shockwave Medical, Inc.


  • Ticker SWAV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,927,100
  • Description
  • ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease ...
More about SWAV
Track This Portfolio

Track Times Square Capital Management, LLC Portfolio

Follow Times Square Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Times Square Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Times Square Capital Management, LLC with notifications on news.